reference/6549129

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6549129

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	897
issn	0003-4967
issueIdentifier	6
pageRange	892-897
publicationName	Annals of the Rheumatic Diseases
startingPage	892
bibliographicCitation	Reinders MK, Haagsma C, Jansen TLTA, van Roon EN, Delsing J, van de Laar MAFJ, Brouwers JRBJ. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout. Annals of the Rheumatic Diseases. 2008 Jul 16;68(6):892–7. doi: 10.1136/ard.2008.091462.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_184411ea52e5b4eab81420ce072e6624 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8096a921db6cb72da31a1c8d34d39eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f1b892c1da6dd7f1a44e6276799e175 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b105b19cffb76f8cb6c915210fcd0856 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cbb1beaaeb41a0d856d37c7c7b0ffef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da02674875048e8a80b3eda89412a963 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21cb03f22101002d517a44564f16be49
date	2008-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/18633127 https://doi.org/10.1136/ard.2008.091462
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/640 https://portal.issn.org/resource/ISSN/0003-4967
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout
discusses	http://id.nlm.nih.gov/mesh/M0002331 http://id.nlm.nih.gov/mesh/M0000745 http://id.nlm.nih.gov/mesh/M0022340 http://id.nlm.nih.gov/mesh/M0022342 http://id.nlm.nih.gov/mesh/M0015696 http://id.nlm.nih.gov/mesh/M0009558
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014528Q000008 http://id.nlm.nih.gov/mesh/D006074Q000008 http://id.nlm.nih.gov/mesh/D000493Q000008 http://id.nlm.nih.gov/mesh/D001553Q000008 http://id.nlm.nih.gov/mesh/D006073Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D006074Q000627 http://id.nlm.nih.gov/mesh/D014527Q000097 http://id.nlm.nih.gov/mesh/D010349 http://id.nlm.nih.gov/mesh/D014528Q000627 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006074Q000009 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000493Q000627 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D000493Q000009 http://id.nlm.nih.gov/mesh/D064420 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016001 http://id.nlm.nih.gov/mesh/D010117Q000097 http://id.nlm.nih.gov/mesh/D001553Q000627 http://id.nlm.nih.gov/mesh/D014528Q000009 http://id.nlm.nih.gov/mesh/D001553Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006073Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2333 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135401907 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7872

Incoming Links

Predicate

Subject

http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129582974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID76715662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128127377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128476887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53789288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128799971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861

Total number of triples: 71.